Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067418 · ClinicalTrials.gov registry record
Light Scattering Spectroscopy to Determine Brain Tumors
A clinical trial of Epilepsy, Temporal Lobe and Temporal Lobe, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00067418 is a study of Epilepsy, Temporal Lobe and Temporal Lobe that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 50 participants, below the 400-participant average among 4 other Epilepsy, Temporal Lobe trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00067418, a study of Epilepsy, Temporal Lobe and Temporal Lobe, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use light scattering spectroscopy (LSS) to analyze brain tissue removed from patients during brain surgery to determine if this new technology can be used to differentiate between normal and cancerous cells. LSS focuses light on cells or tissues, and the way that light is reflected back from the tissues provides information about the size of cells and the density of the cell nuclei (the part of the cell that contains the genes). Patients between 18 and 75 years of age with a known or suspected brain tumor and patients with temporal lobe epilepsy that does not respond to medication may be eligible for this study. (Examination of tissue from patients with epilepsy will allow comparison of tumor and non-tumor brain cells.) All patients must require surgery to treat their condition. Participants will be admitted to the Clinical Center for 3 to 10 days for physical and neurological examinations, blood and urine tests, and other tests needed to prepare for surgery. They will then undergo surgery. A small amount of tissue removed during surgery for pathological review will be collected for use in this study. Half of the tissue will be examined using LSS to help determine the size of the cell and its nucleus. Studies will be done to measure how many of the cells are actively dividing and which proteins are expressed more often in tumor cells compared with normal cells. This information may shed light on how tumor cells are different from normal cells. Participants may be contacted for up to 3 years to follow their health status.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067418
The ClinicalTrials.gov registry entry for NCT00067418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 400-participant average among 4 other Epilepsy, Temporal Lobe trials with a reported enrollment target (87% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Epilepsy, Temporal Lobe appearing as the primary indexed condition, and to 0 interventions.
NCT00067418 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00067418 about?
NCT00067418 is a clinical study titled "Light Scattering Spectroscopy to Determine Brain Tumors". This study will use light scattering spectroscopy (LSS) to analyze brain tissue removed from patients during brain surgery to determine if this new technology can be used to differentiate between normal and cancerous cells. LSS focuses light on cells or tissues, and the way that light is reflected b...
What is the current status of trial NCT00067418?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2003-08. Estimated completion is 2004-10.
What conditions does trial NCT00067418 study?
This clinical trial studies the following conditions: Epilepsy, Temporal Lobe, Temporal Lobe.
Who is sponsoring clinical trial NCT00067418?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00067418 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy, Temporal Lobe
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgery as a Treatment for Medically Intractable Epilepsy
RECRUITING
-
Investigating Epilepsy: Screening and Evaluation
RECRUITING
-
Localizing Epileptic Networks Using MRI and iEEG
RECRUITING · Early Phase 1
-
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.